You are here
Pharmaceutical Excipients Market Worth $9.7 Billion by 2025 - Exclusive Report by MarketsandMarkets™
CHICAGO, June 28, 2019 /PRNewswire/ -- According to the new market research report "Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohyrates, Petrochemicals) inorganic chemicals), Functionality (Fillers, Diluents, Coatings, Disintegrants), Formulation (Tablet, Capsule, Topical, Parenteral) - Global Forecast to 2025", published by MarketsandMarkets™, the Pharmaceutical Excipients Market is projected to reach USD 9.7 billion by 2025 from USD 6.9 billion in 2019, at a CAGR of 5.8%.
Download PDF Brochure:
Factors such as the growing pharmaceuticals industry coupled with advancements in functional excipients, rising adoption of orphan drugs, and increasing uptake of biopharmaceuticals, are driving the market for pharmaceutical excipients. The emergence of multifunctional excipients, shifting the focus of pharmaceutical manufacturing to emerging markets, and the growing biosimilars industry also present significant growth opportunities for market players.
By functionality, the fillers and diluents segment is expected to account for the largest share of the pharmaceutical excipients market in 2019
The fillers & diluents segment accounted for the largest share of the pharmaceutical excipients market in 2018. This market segment is expected to grow due to the increased use of fillers and diluents in the development and production of solid oral drugs. Oral formulations account for a majority share in the pharmaceutical industry, and as these formulations require fillers and diluents the most, this segment automatically has the majority share of the pharmaceutical excipients market.
Browse in-depth TOC on "Pharmaceutical Excipients Market"
220 – Tables
50 – Figures
300 – Pages
By formulation, the oral formulations segment is estimated to account for the largest share of this market in 2019
Based on formulation, the pharmaceutical excipients market is segmented into oral, topical, parenteral, and other formulations. In 2018, oral formulations accounted for a major share of the pharmaceutical excipients market, mainly because oral formulations are the most common route of drug delivery. Owing to the shrinking pipeline of new chemical entities (NCEs), companies are increasingly focusing on developing orally disintegrating tablets (ODTs) and other novel methods of oral drug delivery. There is also a growing trend towards sachet formulations.
The Asia Pacific is expected to be the fastest growing the market in 2019
In 2018, the Asia Pacific region was seen as the fastest growing region in the pharmaceutical excipients market. The ease of doing business in the Asia Pacific region in terms of reduced regulatory stringency, reduced raw material & labor costs, and a higher target market make this region the fastest growing market in 2019.
Request Research Sample Pages:
The key players in the global pharmaceutical excipients market are Ashland (US), BASF (Germany), DuPont (US), Roquette (France), Evonik Industries (Germany), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol (US), and Croda International (UK).
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Browse Related Reports:
HIGH POTENCY APIS /HPAPI MARKET By Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB, Vaccines, Recombinant Proteins), Manufacturer (Captive and Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance)
ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET By Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone, Biosimilar) Drug (OTC, Rx), Therapy, and Region
SUGAR-BASED EXCIPIENTS MARKET By Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type (Powder/Granule, Crystal, Syrup), Functionality (Filler & Diluent, Tonicity Agents), Formulation (Oral, Topical, Parenteral)
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/pharma-excipients-market.asp
Visit Our Website: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/pharma-excipients.asp